ʻO Coronavirus hou(SARS-Cov-2) pahu ʻimi ʻakika nucleic
New Coronavirus(SARS-Cov-2) Nucleic Acid Detection Kit
(Fluokascent RT-PCR Probe Method) Product Manual
【Product name 】ʻO ka Coronavirus hou(SARS-Cov-2) ka pahu ʻike ʻakika nucleic (Fluorescent RT-PCR Probe Method)
【Packaging specifications 】25 Ho'āʻo/Kiki
【Intended usmakahiki】
Hoʻohana ʻia kēia kit no ka ʻike qualitative o ka waikawa nucleic mai ka coronavirus hou i loko o nā swabs nasopharyngeal, oropharyngeal (puʻi) swabs, nā ʻūhā ihu mua, nā swabs waena waena, nā holoi ihu a me nā aspirates ihu mai nā poʻe i manaʻo ʻia he COVID19 e kā lākou mea mālama olakino. Hiki ke hoʻohana ʻia ka ʻike ʻana i nā genes ORF1ab a me N o ka coronavirus hou no ka maʻi kōkua a me ka nānā ʻana i ka maʻi epidemiological o ka maʻi coronavirus hou.
【Principles of the procedure 】
Hoʻolālā ʻia kēia kime no nā ʻimi kikoʻī TaqMan a me nā kumu mua i hoʻolālā ʻia no ka novel coronavirus (SARS-Cov-2) ORF1ab a me N gene sequences. Aia i loko o ka solution reaction PCR he 3 sets o nā primers kiko'ī a me nā ʻimi fluorescent no ka ʻike pono ʻana i nā pahuhopu, a ua hoʻohana ʻia kekahi pūʻulu o nā primers kikoʻī a me nā ʻimi fluorescent ma ke ʻano he mana maʻamau o loko o ka pahu no ka ʻike ʻana i nā genes mālama hale endogenous.
ʻO ke kumu hoʻāʻo ʻo ia ka hoʻokaʻawale ʻana a hoʻohaʻahaʻa ʻia ka ʻimi fluorescent kikoʻī e ka hana exonuclease o ka enzyme Taq i ka hopena PCR, i hoʻokaʻawale ʻia ka pūʻulu fluorescent reporter a me ka hui fluorescent quenched, i hiki i ka ʻōnaehana nānā fluorescence ke loaʻa i kahi fluorescent. hōʻailona, a laila Ma o ka hoʻonui ʻia ʻana o ka PCR amplification, hiki i ka hōʻailona fluorescence o ka probe i kahi waiwai paepae-Ct waiwai (Cycle threshold). Inā ʻaʻohe amplicon i hoʻopaʻa ʻia, kokoke ka pūʻulu hoʻolaha o ka probe i ka hui quenching. I kēia manawa, hiki ke hoʻololi i ka ikehu fluorescence resonance, a ua kinai ʻia ka fluorescence o ka hui reporter e ka hui quenching, i hiki ʻole ke ʻike ʻia ka hōʻailona fluorescent e ka mea hana PCR fluorescent.
No ka nānā ʻana i ka hoʻohana ʻana i nā reagents i ka wā o ka hoʻāʻo ʻana, ua lako ka pahu me nā mana maikaʻi a maikaʻi ʻole: aia ka mana maikaʻi i ka plasmid recombinant pūnaewele i manaʻo ʻia, a ʻo ka mana maikaʻi ʻole ʻo ka wai Distilled, i hoʻohana ʻia e nānā i ka pollution kaiapuni. Manaʻo ʻia e hoʻonohonoho i kahi mana maikaʻi a me kahi mana maikaʻi ʻole i ka manawa like i ka wā e hoʻāʻo ai.
【Main components 】
Cat. No. | BST-SARS-25 | BST-SARS-DR-25 | Components | |
Name | Specification | Quantkeia | Quantkeia | |
Manaʻo maikaʻi | 180 μL / vial | 1 | 1 | ʻO nā plasmids i hana ʻia i hana ʻia i ke ʻano, ʻO ka wai distilled |
Manaʻo ʻino | 180 μL / vial | 1 | 1 | Wai hoʻoheheʻe |
ʻO SARS-Cov-2 Mix | 358.5 μL / vial | 1 | / | ʻO nā hui mua kikoʻī, nā ʻimi fluorescent ʻike kikoʻī, nā dNTPs, , MgCl2, KCl, Tris-Hcl, wai ʻūlū, etc. |
Huihui Enzyme | 16.5 μL / vial | 1 | / | Taq enzymes, reverse transcriptase, UNG enzymes, etc. |
ʻO SARS-Cov-2 Mix(Lyophilised) | 25 ho'āʻo / vial | / | 1 | ʻO nā hui mua kikoʻī, ʻike kikoʻī fluorescent probes, dNTPs, Taq enzymes, reverse transcriptase, Distilled water, etc. |
2x Hoʻopaʻa | 375 μL / vial | / | 1 | MgCl2, KCl, Tris-Hcl, wai hoʻoheheʻe, etc. |
Nānā:(1) ʻAʻole hiki ke hoʻohui a hoʻololi ʻia nā ʻāpana o nā pahu pahu like ʻole.
(2) E hoʻomākaukau i kāu reagent ponoʻī: Nucleic acid extraction kit.
【Storage conditions a expiration date 】
For BST-SARS-25:ʻO ka lawe a mālama ʻana ma -20±5 ℃ no ka manawa lōʻihi.
For BST-SARS-DR-25:ʻO ka lawe ʻana i ka lumi wela. E kūʻai ma -20±5 ℃ no ka manawa lōʻihi.
E hōʻalo i nā pōʻai hoʻoheheʻe-hau. Hoʻonohonoho ʻia ka manawa kūpono no 12 mau mahina.
E ʻike i ka lepili no ka lā hana a hoʻohana.
Ma hope o ka wehe mua ʻana, hiki ke mālama ʻia ka reagent ma -20 ± 5 ° C no ka mea ʻaʻole i ʻoi aku ma mua o 1 mahina a i ʻole ka pau ʻana o ka manawa reagent, ʻo kēlā me kēia lā e hiki mua mai, e pale i nā pōʻai manuahi-thaw hou, a me ka helu o ka reagent freeze. -ʻaʻole pono eʻoi aku ka nui o nā manawa hoʻoheheʻe ma mua o 6 manawa.
【Applicable instrument】ABI 7500, SLAN-96P, Roche-LightCycler-480.
【Sample requirements 】
1.Applicable laʻanaʻano: Extracted nucleic acid solution.
2.Sample mālama a me ka lawe ʻana: E kūʻai ma-20±5 ℃ no 6 mau mahina. E hoʻokuʻu a hoʻoheheʻe i nā laʻana ma mua o 6 mau manawa.
【Testing method】
1.Nucleic acid extraction
E koho i kahi pahu lawe ʻakika nucleic kūpono no ka unuhi ʻana i ka waika nucleic viral, a e hahai i nā ʻōlelo aʻoaʻo e pili ana. Manaʻo ʻia e hoʻohana i kahi pahu hoʻomaʻemaʻe Nucleic acid i hana ʻia e Yixin Bio-Tech (Guangzhou) Co., Ltd. a i ʻole ka pahu hoʻomaʻemaʻe nucleic acid.
2. Reaction reagent preparation
2.1 For BST-SARS-25:
(1) Wehe i ka SARS-Cov-2 Mix a me Enzyme Mix , hehee loa i ka lumi wela e hui pono me ka Vortex a laila centrifuge pōkole.
(2) Hoʻohui ʻia ʻo 16.5uL Enzyme Mix i ka 358.5uL SARS-Cov-2 Mix a hui maikaʻi ʻia e loaʻa ai ka hopena hoʻohuihui.
(3) E hoʻomākaukau i kahi paipu octal PCR maʻemaʻe 0.2 mL a e kaha iā ia me 15uL o ka hoʻonā hui ʻia ma luna o kēlā me kēia punawai.
(4) E hoʻohui i 15 μL o ka hoʻomaʻemaʻe nucleic acid solution, ka mana maikaʻi a me ka mana maikaʻi ʻole, a uhi pono i ka pāpale octal tube.
(5) Hoʻohui maikaʻi ma ka hoʻohuli ʻana i luna i lalo, a e hoʻokaʻawale wikiwiki i ka wai ma lalo o ka paipu.
1
2.2 For BST-SARS-DR-25:
(1) E hoʻohui i ka 375ul 2x Buffer i ka SARS-Cov-2 Mix((Lyophilised) e hoʻomākaukau ai i ka hui ʻana. E hui pono me ka pipetting a laila centrifuge pōkole. (Ke hoʻomākaukau ʻia ka hui ʻana, pono ia e mālama ma -20 ℃ ma mālama lōʻihi.)
(2) E hoʻomākaukau i kahi paipu octal PCR 0.2 mL maʻemaʻe a e kaha iā ia me 15μL o ka hui ʻana i kēlā me kēia luawai.
(3) E hoʻohui i 15μL o ka hoʻomaʻemaʻe nucleic acid solution, ka mana maikaʻi a me ka mana maikaʻi ʻole, a uhi pono i ka pāpale octal tube.
(4) E hoʻohui maikaʻi ma ka hoʻohuli ʻana i luna i lalo, a me ka centrifuge wikiwiki e hoʻopololei i ka wai ma lalo o ka paipu.
3. PCR amplification (E ʻoluʻolu e nānā i ka manual mea hana no nā hoʻonohonoho hana.)
3. 1 E kau i ka PCR 8-tube i loko o ke keʻena hāpana o ka mea hana PCR fluorescent, a hoʻonoho i ka hāpana e hoʻāʻo ʻia, ka mana maikaʻi a me ka mana maikaʻi ʻole e like me ke kauoha o ka hoʻouka ʻana.
3.2 Kaila ʻike fluorescence:
(1) ORF1ab gene koho i ke ala ʻike o FAM (Reporter: FAM, Quencher: ʻAʻohe).
(2) Koho ʻo N gene i ke ala ʻike o VIC (Reporter: VIC, Quencher: ʻAʻole).
(3) Koho ka gene maʻamau kūloko i ke ala ʻike o CY5 (Reporter: CY5, Quencher: ʻAʻohe).
(4) Hoʻonohonoho ʻia ka Passive Reference iā ROX.
3.3 Ka hoʻonohonoho ʻana o ka ʻāpana polokalamu PCR:
ʻanuʻu | Mahana (℃) | Manawa | Ka helu o nā pōʻaiapuni | |
1 | Hoʻihoʻi ʻia ka hana unuhi | 50 | 15 min | 1 |
2 | Taq enzyme ho'ā | 95 | 2.5 min | 1 |
3 | Taq enzyme ho'ā | 93 | 10 s | 43 |
ʻO ka hoʻonui ʻana a me ka loaʻa ʻana o ka fluorescence | 55 | 30 s |
Ma hope o ka hoʻonohonoho ʻana, mālama i ka faila a holo i ka papahana pane..
4.Results analysis
Ma hope o ka pau ʻana o ka papahana, mālama ʻia nā hopena, a nānā ʻia ka pihi hoʻonui. Hoʻonohonoho ʻia ka pihi hoʻonui i ka paepae paʻamau mea kani.
【Explanation of test results 】
1. E hoʻoholo i ka pono o ka hoʻokolohua: ʻO ka mana maikaʻi FAM, VIC channel e loaʻa i kahi pihi hoʻonui maʻamau, a ʻo ka waiwai Ct ma lalo o 34, akā hiki ke loli ma muli o nā pae paepae ʻokoʻa o nā mea kani like ʻole. ʻO ka mana maikaʻi ʻole FAM, VIC channel pono e hoʻonui ʻole ʻia Ct. Ua ʻae ʻia e hoʻokō ʻia nā koi i luna i ka manawa like, inā ʻaʻole pono kēia hoʻāʻo.
2. Hoʻoholo i ka hopena
Kaila FAM/VIC | Ka hopena hoʻokolokolo |
Kt<37 | Maikaʻi ka hōʻike laʻana |
37≤Ct<40 | ʻO ke ʻano o ka hoʻonui ʻana he S-like, a pono e nānā hou ʻia nā laʻana kānalua; inā kūlike nā hopena o ka hoʻokolokolo hou ʻana, ua manaʻo ʻia he maikaʻi, inā ʻaʻole ia he ʻino |
Ct≥40 A i ʻole Hoʻonui ʻia | He ʻino ka hoʻāʻo laʻana (a i ʻole ma lalo o ka palena haʻahaʻa o ka ʻike kit) |
'Ōlelo Aʻo: (1) Inā maikaʻi ke ala FAM a me ke ala VIC i ka manawa like, ua paʻa ka SARS-Cov-2 i ka maikaʻi.
(2) Inā maikaʻi ke ala FAM a i ʻole kaila VIC a maikaʻi ʻole ke ala ʻē aʻe, pono e hana hou i ka hoʻāʻo. Inā maikaʻi ia i ka manawa like, e hoʻokolokolo ʻia ʻo ia ʻo SARS-Cov-2 maikaʻi, inā ʻaʻole e hoʻokolokolo ʻia ʻo SARS-Cov-2 maikaʻi ʻole.